Longwood Fund

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

Calithera Achieves Positive Topline Results in Randomized Phase 2 Study in Renal Cell Carcinoma

June 18, 2019

Colorescience® Announces US Patent for Total Eye® 3-in-1 Renewal Therapy SPF 35

June 11, 2019

PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years of Age

June 7, 2019

Axial Therapeutics Announces Publication of Preclinical Data Highlighting the Link Between Human Gut Microbiota and Behavioral Symptoms of Autism Spectrum Disorder in Mouse Models

May 31, 2019

GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study

May 31, 2019

Bicycle Therapeutics Announces Pricing of Initial Public Offering

May 22, 2019
« Older Entries
Newer Entries »

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1715
Boston, MA, 02199

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved